Nabriva Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	12.54	47.83	41.59	86.41	102	86.77	32.78	36.45	1.95	3.95
Short-Term Investments	0	0.02	0.02	0.18	0.23	0.11	51.11	74.99	0	0
Cash & Cash Equivalents	12.54	47.85	41.61	86.59	102.23	86.88	83.88	111.44	1.95	3.95
Cash Growth	-73.80%	15.01%	-51.95%	-15.30%	17.67%	3.57%	-24.73%	5623.68%	-50.75%	-
Receivables	6.74	12.75	3.91	3.12	4.3	5.83	5.98	4.63	2.06	1.49
Inventory	9.68	14.51	5.82	0.68	0	0	0	0	0	0
Other Current Assets	2.15	5.16	5.88	0.78	2.23	1.13	0.76	0.18	-0.36	-0.32
Total Current Assets	31.1	80.27	57.22	91.17	108.75	93.84	90.62	116.25	3.64	5.11
Property, Plant & Equipment	0.28	0.23	0.77	2.47	1.14	1.33	0.52	0.42	0.35	0.4
Goodwill and Intangibles	0	0.03	0.08	0.09	0.1	0.17	0.27	0	0.01	0.02
Other Long-Term Assets	0.38	0.38	0.37	0.38	0.43	0.43	1.83	1.05	0.36	0.32
Total Long-Term Assets	0.66	0.64	1.22	2.94	1.67	1.92	2.62	1.47	0.72	0.74
Total Assets	31.77	80.91	58.44	94.11	110.42	95.76	93.24	117.71	4.36	5.86
Accounts Payable	5.43	4.37	2.89	4.67	3.3	5.14	2.55	2.93	0.32	0.41
Deferred Revenue	0	0.37	0.75	0	0	0	0	0	0	0
Current Debt	4.83	3.77	2.04	0	0	0	0	0	27.67	12.51
Other Current Liabilities	17.34	13.83	12.84	11.97	14.5	8.12	13.33	5.99	3.76	3.57
Total Current Liabilities	27.61	22.34	18.52	16.64	17.81	13.26	15.88	8.92	31.76	16.5
Long-Term Debt	0.39	4.27	5.69	34.5	23.72	0.23	0	0	5.12	7.73
Other Long-Term Liabilities	0.48	0.95	1.09	1.7	0.26	0.2	0.11	0.08	0.66	0.14
Total Long-Term Liabilities	0.87	5.22	6.78	36.2	23.98	0.44	0.11	0.08	5.78	7.87
Total Liabilities	28.47	27.56	25.3	52.84	41.79	13.7	15.98	9.01	37.53	24.37
Total Debt	5.22	8.03	7.73	34.5	23.72	0.23	0	0	32.79	20.25
Debt Growth	-34.98%	3.92%	-77.60%	45.47%	10123.28%	-	-	-	61.94%	-
Retained Earnings	-652.86	-595.68	-546.23	-476.74	-393.98	-279.2	-204.84	-171.43	-106.6	-91.88
Comprehensive Income	0.03	0.03	0.03	0.03	0.03	0.03	0.01	3.83	0	0
Shareholders' Equity	3.29	53.35	33.14	41.27	68.63	82.07	77.26	108.71	-33.17	-18.51
Net Cash / Debt	7.32	39.82	33.88	52.08	78.51	86.65	83.88	111.44	-30.84	-16.29
Net Cash / Debt Growth	-81.63%	17.54%	-34.95%	-33.66%	-9.39%	3.29%	-24.73%	-	-	-
Net Cash Per Share	2.73	22.96	65.94	175.49	386.40	726.16	976.38	2632.28	-23743.57	-
Working Capital	3.5	57.93	38.69	74.53	90.95	80.58	74.74	107.32	-28.11	-11.38
Book Value Per Share	0.12	3.08	6.45	13.91	33.78	68.78	89.92	256.77	-2554.25	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).